Industry News
Investigational personalized cellular therapy tolerated well by patients
4/22/2015
Promising results of Phase I trial show successful migration of immune cells to tumor sitesGenetically modified versions of patients' own immune cells successfully traveled to tumors they were...
New subsets of lung cancer with KRAS gene mutations identified
4/22/2015
Mutations of the KRAS gene are commonly known to lead to cancer. However, deeper understanding of exactly how they do this continues to be explored by cancer researchers.
Driver of non-small cell lung cancer, FGFR1, also in 23 percent of small cell lung cancer
4/22/2015
Significant new treatments are available or in clinical trials for non-small cell lung cancer.
Oral milk thistle extract stops colorectal cancer stem cells from growing tumors
4/22/2015
In results presented at the American Association for Cancer Research (AACR) Annual Meeting 2015, a University of Colorado Cancer Center study shows that orally administering the chemical silibinin...
NFCR-supported scientists discover key factor in brain cancer resistance
4/22/2015
Researchers at the NFCR Center for Cancer System Informatics at MD Anderson Cancer Center have discovered a key factor that may explain drug resistance in glioblastoma (GBM), the most common and...
Cancer drug shows promise as cure for hepatitis B
4/22/2015
Australian scientists have found a potential cure for hepatitis B virus (HBV) infections, with a promising new treatment proving 100 per cent successful in eliminating the infection in preclinical...
A common nerve protein elevated in aggressive neuroblastomas
4/22/2015
A protein produced by nerve cells appears to be elevated in the blood of those with an aggressive form of neuroblastoma.
Shared risk factors lead to diabetes, heart disease and cancer, says major AACR symposium
4/22/2015
In a major symposium at the American Association for Cancer Research (AACR) Annual Meeting 2015, University of Colorado Cancer Center investigator Tim Byers, MD, MPH, describes research showing the...
Gene signatures predict doxorubicin response in K9 osteosarcoma
4/22/2015
COXEN gene expression model matches dogs with bone cancer to most effective drugThere are two chemotherapies commonly used to treat bone cancer in dogs: doxorubicin and carboplatin.
Animal study shows why long-time consumption of soyfoods reduces breast cancer recurrence
4/22/2015
Women diagnosed with breast cancer are often told not to eat soyfoods or soy-based supplements because they can interfere with anti-estrogen treatment.